Company intelligence / Profile preview

ColonaryConcepts

Newton, Massachusetts, United Statescolonaryconcepts.com ↗

Ownership: Private
Development stage: Phase 2

Overview

The lead product candidate, C-Bar™, a novel treatment for chronic constipation, was in Phase 1b clinical trials. The company previously developed a unique colonoscopy prep integrated into food forms and sold those assets to another specialty pharma firm. It continues to advance its patient-friendly GI therapy platform targeting various types of constipation.

Therapeutic areas: Gastroenterology
Modalities: Nutritionally balanced bars and beverages with active pharmaceutical ingredients
Industry: Biotech

Drug pipeline

2 assets

EC Prep

Phase 2

Indications: Colorectal cancer screening preparation

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on ColonaryConcepts.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ColonaryConcepts.

Explore the full profile